Myocardial Infarction Research

Myocardial infarction (MI) - more commonly referred to as a heart attack - is an acute event caused by the interruption of blood supply to regions of the heart, leading to myocardial necrosis. Infarction of a substantial area of the myocardium can disrupt normal conductance of the heart, leading to cardiac arrest.In the majority of cases, an MI is immediately preceded by the presence of an occlusive thrombus within a coronary artery, blocking blood flow to the downstream tissue. The most common cause of an occlusive thrombus within a coronary artery is the rupture of an atherosclerotic plaque. However, the occlusion of a coronary artery may also result from coronary embolism. This can occur in patients following stent placement, angioplasty, and coronary artery bypass grafting.

Myocardial Infarction Research Products Targets

Products for Myocardial Infarction Research - Page 24

  1. Cat.No. Product Name Information/Activity
  2. BCC7808 NAADP tetrasodium salt 5502-96-5 NAADP tetrasodium salt chemical structure
  3. BCC7079 Suramin hexasodium salt Suramin sodium salt (Suramin hexasodium salt) is a reversible and competitive protein-tyrosine phosphatases (PTPases) inhibitor. Suramin sodium salt is a potent inhibitor of sirtuins: SirT1 (IC50=297 nM), SirT2 (IC50=1.15 μM), and SirT5 (IC50=22 μM). Suramin sodium salt is a competitive inhibitor of reverse transcriptase (DNA topoisomerase II: IC50=5 μM). Suramin sodium salt is an antitrypanosomal, anti-neoplastic and anti-angiogenic agent. Suramin hexasodium salt chemical structure
  4. BCC6673 Dantrolene, sodium salt 14663-23-1 Dantrolene, sodium salt chemical structure
  5. BCC7067 Ruthenium Red 11103-72-3 Ruthenium Red chemical structure
  6. BCC5742 Ryanodine Ryanodine is a cell permeant ryanodine receptor modulator. Ryanodine can either stimulate or inhibit Ryanodine-mediated Ca2+ release depending on its concentrations. Poisonous diterpenoid found in Ryania speciosa. Ryanodine chemical structure
  7. BCC6644 ML 9 hydrochloride ML-9 is a selective and potent inhibitor of Akt kinase, inhibits myosin light-chain kinase (MLCK) and stromal interaction molecule 1 (STIM1) activity. ML-9 inhibits inhibits MLCK, PKA and PKC activity with Ki values of 4, 32 and 54 μM, respectively. ML-9 induces autophagy by stimulating autophagosome formation and inhibiting their degradation. ML 9 hydrochloride chemical structure
  8. BCC6953 SKF 96365 hydrochloride SKF-96365 hydrochloride is a non-selective TRP Channel blocker. SKF 96365 hydrochloride chemical structure
  9. BCC7817 YM 58483 YM-58483 is the first selective and potent inhibitor of CRAC channels and subsequent Ca2+ signals. YM 58483 chemical structure
  10. BCC3918 (±)-Bay K 8644 Ca<sup>2+</sup> channel activator (L-type); aids generation of iPSCs from MEFs (±)-Bay K 8644 chemical structure
  11. BCC7108 (S)-(-)-Bay K 8644 (S)-(-)-Bay-K-8644 is an agonist of L-type Ca2+ channel. (S)-(-)-Bay-K-8644 activates Ba2+ currents (IBa) (EC50=32 nM). (S)-(-)-Bay K 8644 chemical structure

Items 231 to 240 of 400 total